Showing results (151-160 of 232) with videos related to

Sort By:
Pageof 24
Deutsche Medizinische Wochenschrift (1946)|December 16, 1994
[Incompatibility of tuberculosis therapy in a patient with AIDS]D Ziegler, H Lode, M Raffenberg, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1983
Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal floraB Kemmerich, H Warns, H Lode, et al.
Deutsche Medizinische Wochenschrift (1946)|February 14, 2008
[Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance]M W Pletz, U Maus, J M Hohlfeld, et al.
Journal of Chemotherapy (Florence, Italy)|August 19, 2000
Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study groupT File, B Schlemmer, J Garau, et al.
Deutsche Medizinische Wochenschrift (1946)|April 22, 1977
[A multi-centre study of reproterol, a bronchodilator (author's transl)]D Nolte, G Galgóczy, H Lode, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1983
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactamB Kemmerich, H Lode, G Belmega, et al.
Pneumologie (Stuttgart, Germany)|February 1, 1990
[Value of diagnostic procedures in fiberoptic bronchoscopy of pulmonary infections]D Mainz, N Mülleneisen, G Höffken, et al.
The European Respiratory Journal|April 1, 1992
Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokersT Schaberg, H Haller, M Rau, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1989
Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acidK M Deppermann, H Lode, G Höffken, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adultsT M File, H Lode, H Kurz, et al.
Pageof 24